Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zimmer Biomet Holdings (ZBH)

Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,796,744
  • Shares Outstanding, K 198,182
  • Annual Sales, $ 7,679 M
  • Annual Income, $ 903,700 K
  • EBIT $ 1,978 M
  • EBITDA $ 2,975 M
  • 60-Month Beta 0.61
  • Price/Sales 2.30
  • Price/Cash Flow 6.76
  • Price/Book 1.38

Options Overview Details

View History
  • Implied Volatility 24.00% (-1.04%)
  • Historical Volatility 22.33%
  • IV Percentile 26%
  • IV Rank 16.55%
  • IV High 48.79% on 04/08/25
  • IV Low 19.09% on 02/06/25
  • Expected Move (DTE 24) 3.70 (4.13%)
  • Put/Call Vol Ratio 13.11
  • Today's Volume 2,229
  • Volume Avg (30-Day) 407
  • Put/Call OI Ratio 1.24
  • Today's Open Interest 10,201
  • Open Int (30-Day) 12,046
  • Expected Range 85.73 to 93.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.38
  • Number of Estimates 10
  • High Estimate 2.43
  • Low Estimate 2.35
  • Prior Year 2.31
  • Growth Rate Est. (year over year) +3.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
88.50 +1.05%
on 12/19/25
98.34 -9.06%
on 11/28/25
-2.75 (-2.98%)
since 11/21/25
3-Month
85.33 +4.80%
on 11/06/25
106.88 -16.33%
on 10/22/25
-10.86 (-10.83%)
since 09/23/25
52-Week
85.33 +4.80%
on 11/06/25
114.44 -21.85%
on 04/03/25
-17.39 (-16.28%)
since 12/23/24

Most Recent Stories

More News
Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference

WARSAW, Ind. , Dec. 22, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team...

ZBH : 89.43 (-0.41%)
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2025

WARSAW, Ind. , Dec. 17, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment...

ZBH : 89.43 (-0.41%)
Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery

OneStep's Clinically Validated Mobility Intelligence Technology to Integrate into Zimmer Biomet's mymobility ® Care Management Platform to Further Enhance Recovery Monitoring

ZBH : 89.43 (-0.41%)
Zimmer Biomet Stock: Is ZBH Underperforming the Health Care Sector?

Despite Zimmer Biomet's underperformance relative to the broader healthcare sector over the past year, the stock is still viewed by analysts with moderate optimism.

ZBH : 89.43 (-0.41%)
XLV : 154.99 (-0.20%)
PEN : 315.95 (-1.53%)
Zimmer Biomet, Cigna, Universal Health Services, Henry Schein, and Sotera Health Company Shares Skyrocket, What You Need To Know

Zimmer Biomet, Cigna, Universal Health Services, Henry Schein, and Sotera Health Company Shares Skyrocket, What You Need To Know

ZBH : 89.43 (-0.41%)
UHS : 227.27 (+0.28%)
HSIC : 76.50 (-1.39%)
CI : 273.75 (-0.67%)
SHC : 17.41 (+0.75%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zimmer Biomet Holdings, Inc. - ZBH

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Zimmer Biomet Holdings, Inc. ("Zimmer Biomet" or the "Company") (NYSE: ZBH). Such investors...

ZBH : 89.43 (-0.41%)
Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman

SAN FRANCISCO , Nov. 18, 2025 /PRNewswire/ -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced...

ZBH : 89.43 (-0.41%)
Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology

ROSA ® Knee with OptimiZe ™ Offers Personalized Surgical Planning and Drives Confidence in Delivering Accurate and Reproducible Outcomes 1

ZBH : 89.43 (-0.41%)
Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH ) investors concerning the Company’s...

ZBH : 89.43 (-0.41%)
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Glancy Prongay & Murray LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the...

ZBH : 89.43 (-0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products....

See More

Key Turning Points

3rd Resistance Point 90.98
2nd Resistance Point 90.44
1st Resistance Point 89.93
Last Price 89.43
1st Support Level 88.88
2nd Support Level 88.34
3rd Support Level 87.83

See More

52-Week High 114.44
Fibonacci 61.8% 103.32
Fibonacci 50% 99.89
Fibonacci 38.2% 96.45
Last Price 89.43
52-Week Low 85.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar